Helena Napier is an illustrator, graphic designer and animator currently living and working in London. Here she shares how her temporal lobe epilepsy was undiagnosed for seven years and its impact on ...

A late-stage study has shown promising results for the effectiveness of fenfluramine in people with an ultra-rare form of epilepsy - CDKL5 deficiency disorder (CDD). CDD affects approximately one in ...

A new project in Australia is using AI to fast-track the time between diagnosis and seizure control, with the aim of improving outcomes for people with epilepsy. Advancements in technology are ...

Epilepsy Society has welcomed new plans to boost clinical trials in the UK as part of the NHS 10-year health plan. The government has announced that millions of people will now be able to search for ...

A survey* carried out by the Epilepsy Society showed that 62 per cent of people with uncontrolled seizures experience an increase in their seizure activity during unusually hot weather. It is ...

Updated safety and educational materials have been published for the anti-seizure medication valproate*. You should never stop taking valproate without first consulting your doctor. The updates ...

As part of the reforms to the NHS, millions more patients will receive appointments, screening invitations and other important information directly via the NHS App as part of the digital-first upgrade ...

Our exhibition in the House of Commons for National Epilepsy Week has really pushed epilepsy up the political agenda. We held a reception last Wednesday 21st May with guest speakers including the ...

A huge thank you to Becca and the amazing team at Gemini Chocolate in Beverley, East Yorkshire, who raised an incredible £1,000 for the Epilepsy Society around Valentine’s Day.

We are thrilled to announce that Sanjay Sisodiya has been appointed to the new role of Transformation Director at the Epilepsy Society. Professor Sisodiya will combine this role with his clinical and ...

The Epilepsy Society has welcomed the findings of an international study that throws new light on why some people with focal epilepsy do not respond to anti-seizure medications. It is the first ...